Search

everythinglearnresearchcommunity

for

Search:↓

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.

Keratin 15 expression in skin cells is regulated by two mechanisms involving PKC/AP-1 and FOXM1.

JAK inhibitors show promise for treating various skin diseases.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Gray hair can potentially be reversed, leading to new treatments.

Adipose tissue-derived exosomes may help regrow hair in alopecia areata.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Current treatments for androgenetic alopecia are complex and promising, but more research is needed.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

XIST RNA helps regenerate hair follicles by targeting miR-424 and activating hedgehog signaling.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Stem cell niches are adaptable and key for tissue maintenance and repair.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Minoxidil foam helps hair growth by increasing good proteins and decreasing bad pathways in men with hair loss.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.